Sjogren syndrome

Reading File
Finding Sources
Searching PubMed

"Sjogren syndrome"[MeSH Terms]

Finding Sources
Reading File
Searching PubMed

"Sjogren syndrome"[MeSH Terms] AND diagnosis

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Reading File
I now have very comprehensive information from multiple textbooks. Let me compile the full answer.

Sjögren Syndrome

Definition and Epidemiology

Sjögren syndrome (SjS) is a chronic autoimmune inflammatory disorder of the exocrine glands - primarily the salivary and lacrimal glands - characterized by lymphoplasmacytic infiltration and resulting glandular hypofunction. The hallmark presentation is the sicca complex: xerostomia (dry mouth) and keratoconjunctivitis sicca (dry eyes).
  • Prevalence: 1-3% of the population
  • Sex: >90% of patients are women (female-to-male ratio ~9:1)
  • Age of onset: Most commonly in the 4th-5th decades of life
  • Classification:
    • Primary SjS: Sicca complex alone, not associated with another autoimmune disease
    • Secondary SjS: Sicca complex occurring alongside another autoimmune disease (most commonly rheumatoid arthritis, SLE, scleroderma, polymyositis, or primary biliary cholangitis)

Pathogenesis

The etiology involves a three-way interaction of genetics, the immune system, and environment:
  1. Genetic predisposition: HLA alleles B8 and DR3 confer susceptibility
  2. Environmental trigger: Most likely a viral infection acts as the inciting event
  3. Aberrant autoimmune response:
    • Dense lymphocytic infiltration of exocrine glands
    • B-cell overstimulation producing excess immunoglobulins and autoantibodies
    • Formation of germinal centers within salivary glands, allowing autoreactive B-cell clones to escape tolerance checkpoints
    • Elevated follicular helper T-cell levels contribute to disease development
    • Autoantibodies against M3-muscarinic acetylcholine receptors impair glandular secretion
Key autoantibodies:
  • Anti-Ro/SS-A (60 kDa ribonucleoprotein, also associated with Ro52/TRIM21)
  • Anti-La/SS-B (48 kDa protein, almost always accompanied by anti-SS-A)
  • Also: ANA (homogeneous or speckled pattern), rheumatoid factor, cryoglobulins, hypergammaglobulinemia

Clinical Features

Glandular (Sicca Complex)

Oral (Xerostomia):
  • Difficulty chewing, swallowing, and speaking
  • Dental caries (often rampant)
  • Adherence of food to buccal mucosa
  • Intolerance to acidic/spicy foods
  • Smooth, fissured tongue with papillary atrophy
  • Oral candidiasis (Candida albicans overgrowth)
  • Absence of pooled saliva in the floor of the mouth
  • Scant or cloudy saliva from ducts
  • Parotid gland enlargement in 25-66% of patients - may be unilateral initially, but typically bilateral; can be episodic or chronic
Ocular (Keratoconjunctivitis Sicca):
  • "Gritty" or "sandy" foreign body sensation
  • Dilated bulbar conjunctival vessels, periorneal injection
  • Corneal epithelial irregularity
  • Occasional lacrimal gland enlargement
Bilateral parotid gland enlargement in a middle-aged woman with Sjögren syndrome
Bilateral parotid gland enlargement in Sjögren syndrome - Cummings Otolaryngology, p. 1498

Systemic (Extraglandular) Manifestations

Occur in approximately one-third of patients:
SystemManifestations
ConstitutionalFatigue, generalized malaise, low-grade fever, myalgia, arthralgia
PulmonaryDryness of pharynx/trachea, bronchitis, pneumonia; NSIP (most common ILD pattern), lymphoid interstitial pneumonia (LIP), amyloidosis
RenalTubulointerstitial nephritis, distal renal tubular acidosis, impaired concentrating ability, hypercalciuria; rarely glomerulonephritis (mesangial, MPGN, membranous)
VascularRaynaud phenomenon, recurrent urticaria-like lesions; vasculitis in 20-30%
NeurologicPeripheral sensory and motor polyneuropathies (10-30% of primary SjS); sensory ataxic neuronopathy; small-fiber neuropathy; trigeminal sensory neuropathy; autonomic neuropathy (cardiac parasympathetic dysfunction, anhidrosis, Adie pupil)
SkinCutaneous vasculitis, dry skin, vaginal dryness
GI/EndocrineDysphagia, esophageal dysmotility; associated with primary biliary cholangitis, chronic active hepatitis, Crohn disease, thyroid disease
LymphoproliferativeIncreased risk of B-cell lymphoma (esp. MALT type) - risk persists for >2 decades; also Waldenström macroglobulinemia
Key risk: Persistent unilateral or bilateral parotid enlargement is a warning sign for lymphoma development.

Diagnosis

Objective Tests

Ocular evaluation:
  • Schirmer test: <8 mm wetting per 5 minutes (or <5 mm in modified test) indicates reduced tear production
  • Rose Bengal staining: Stains damaged corneal and conjunctival epithelia - positive in keratoconjunctivitis sicca
Salivary evaluation:
  • Salivary flow rate (Lashley cups over Stensen duct)
  • Sialography: Demonstrates sialectasis in 85-97% of SjS patients
Tissue biopsy:
  • Minor salivary gland biopsy (labial) is the most consistent feature of primary SjS; should include several glandular lobes from areas with normal overlying mucosa
  • Histopathology: Focal lymphocytic sialadenitis - multiple mononuclear aggregates adjacent to and replacing normal acini; focus score ≥1 (foci/4 mm²) is diagnostic
Serology:
  • Anti-Ro/SS-A and anti-La/SS-B antibodies (ELISA)
  • ANA (>1:320), RF (>1:320)
  • Elevated ESR, hypergammaglobulinemia

Diagnostic Criteria

San Diego Criteria (Fox et al.) requires all three for definite SjS:
CriterionDetails
A - OcularSchirmer test <8 mm/5 min AND positive Rose Bengal staining
B - OralDecreased parotid flow rate AND minor salivary gland biopsy (focus score ≥1)
C - SerologicElevated RF (>1:320), ANA (>1:320), or anti-SS-A/SS-B
Probable SjS can be diagnosed without biopsy (criteria A, B-1 oral flow only, and C).
Exclusions: HIV infection, hepatitis B/C, sarcoidosis, preexisting lymphoma, primary fibromyalgia, keratitis sicca from other causes.
Note: Patients with HIV or hepatitis C virus can present with sicca complex that mimics SjS - these must be excluded before diagnosing SjS.

Pulmonary Radiology (HRCT Findings)

  • NSIP is the most common ILD pattern
  • LIP (lymphoid interstitial pneumonia): thin-walled cysts + ground-glass opacity
  • Association of LIP with amyloidosis produces multiple irregular nodules with cysts
  • Mild bronchiectasis is common
  • Finding of LIP + nodules/consolidations should raise concern for pulmonary lymphoma

Neurology in Sjögren Syndrome

Peripheral nerve involvement occurs in 10-30% of primary SjS patients and may precede sicca symptoms:
  • Most common: Distal symmetrical sensory neuropathy (mixed large/small fiber)
  • Sensory ataxic neuronopathy (dorsal root ganglionopathy) - loss of kinesthesia/proprioception; may mimic spinocerebellar ataxia
  • Small-fiber neuropathy, polyradiculoneuropathy, multiple mononeuropathies
  • Trigeminal sensory neuropathy, autonomic neuropathy
  • EMG/NCS: Reduced/absent SNAPs, normal or mildly abnormal motor conduction
  • MRI cervical cord: T2 hyperintensity in posterior columns in sensory ganglionopathy

Treatment

Symptomatic Management

ProblemTreatment
XerostomiaChew sugarless gum/candy (local stimulation); pilocarpine 5 mg TID-QID (muscarinic agonist sialagogue) - side effects: sweating, flushing, urinary frequency; saliva substitutes
Dental cariesFluoride treatment, preventive dental care
KeratoconjunctivitisArtificial tear lubricants; eye patching if corneal ulceration develops
Oral candidiasisAntifungal agents

Disease-Modifying / Systemic Treatment

IndicationTreatment
Systemic disease / B-cell depletionRituximab (anti-CD20 monoclonal antibody) - reduces both peripheral and salivary gland B-cell subsets; improves xerostomia, fatigue, joint tenderness. Note: not beneficial for low disease activity
Severe extraglandular complications (glomerulonephritis, necrotizing vasculitis)Systemic corticosteroids ± cytotoxic immunosuppressants
Emerging therapiesBelimumab (anti-BAFF), abatacept (CTLA4-Ig) - promising in preliminary trials

Salivary Gland-Specific

  • Sialendoscopy: Dilation and irrigation of affected ducts for recurrent sialadenitis - reduces intensity/frequency of episodes
  • Gland excision: If all other treatments fail
  • Unilateral enlargement despite known SjS should raise suspicion for tumor

Key Associations and Complications

  • Lymphoma risk is elevated even after 2+ decades of benign disease - primary SjS is the autoimmune condition with the highest lymphoma risk (predominantly marginal zone / MALT lymphoma)
  • Renal tubular acidosis can present with hypokalemic periodic paralysis
  • Neonatal lupus/congenital heart block: anti-Ro/SS-A antibodies in pregnant women with SjS can cross the placenta
  • Lab: Serum complement is generally normal in primary SjS (unlike SLE); low complement suggests associated cryoglobulinemia or secondary SjS-SLE overlap

Sources: Cummings Otolaryngology Head and Neck Surgery, p. 1497-1499 | Textbook of Family Medicine 9e, p. 698-700 | Brenner and Rector's The Kidney, p. 1487 | Bradley and Daroff's Neurology, p. 2699 | Grainger & Allison's Diagnostic Radiology, p. 238 | Henry's Clinical Diagnosis and Management by Laboratory Methods, p. 1521-1528
This is a shared conversation. Sign in to Orris to start your own chat.